Vergleichbarkeit internationaler Arzneimittelpreise

Literatur

Breyer, F., Zweifel, P. und M. Kifmann (2013): Preisregulierung der Arzneimittel. in: Breyer, F., Zweifel, P., und M. Kifmann (Hrsg.): Gesundheitsökonomik, Vol. 6, Berlin, Springer, S. 498–508.10.1007/978-3-642-30894-9Search in Google Scholar

Burg, F. (2011): Zur Berechnung von Kaufkraftparitäten. Wirtschaft und Statistik, Nr. 8, S. 793–801.Search in Google Scholar

Carone, G., Schwierz, C. und A. Xavier (2012): Cost-containment Policies in Public Pharmaceutical Spending in the EU. Europäische Kommission – Directorate-General for Economic and Financial Affairs, Economic Papers 461.10.2139/ssrn.2161803Search in Google Scholar

Cassel, D. und V. Ulrich (2012): Herstellerabgabepreise auf europäischen Arzneimittelmärkten als Erstattungsrahmen in der GKV‐Arzneimittelversorgung: Zur Problematik des Konzepts internationaler Vergleichspreise. Gutachten für den VFA, Berlin.Search in Google Scholar

Culyer, A.J. (1982): The NHS and the Market: Images and Realities. In: Maynard, A., und G. McLachlan (Hrsg.), The Public-Private Mix for Health: The Relevance and Effects of Change, Nuffield Provincial Hospitals Trust, London, S. 23–55.Search in Google Scholar

Danzon, P. M. (1997): Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EU. International Journal of the Economics of Business, 4(3), S. 301–322.10.1080/758523212Search in Google Scholar

Danzon, P. und A. Towse (2003): Differential pricing for pharmaceuticals: reconciling access, R&D and patents. International Journal of Health Care Finance and Economics, 3(3), S. 183–205.10.1023/A:1025384819575Search in Google Scholar

Danzon, P., Towse, A. und J. Mestre-Ferrandiz (2013): Value-based differential pricing: Efficient prices for drugs in a global context. Health Economics, 22(12), S. 1405–1514.10.3386/w18593Search in Google Scholar

Deutscher Bundestag (2012): Änderungsantrag 2 – Änderung des Fünften Buches Sozialgesetzbuch. BT-Drucks 17/9341, Berlin.Search in Google Scholar

Égert, B. (2007): Real convergence, price level convergence and inflation differentials in Europe. CESifo Working Paper No. 2127.Search in Google Scholar

Europäische Kommission (2009a): Das BIP und mehr. Die Messung des Fortschritts in einer Welt im Wandel. Mitteilung der Europäischen Kommission an den Rat und das Europäische Parlament. KOM (2009), 433, Brüssel.Search in Google Scholar

Europäische Kommission (2009b): Pharmaceutical Sector Inquiry – Final Report. Europäische Kommission – DG Competition. Abgerufen am 18.08.2013, von: http://ec.europa.eu/competition/sectors/pharmaceuticals/inquiry/.Search in Google Scholar

Eurostat (2012): Eurostat-OECD Methodological Manual on Purchasing Power Parities. EUROSTAT-OECD, Paris.Search in Google Scholar

Gerdtham, U. und B. Jonsson (1991): Conversion factor instability in international comparisons of health care expenditure. Journal of Health Economics, 10(2), S. 227–234.10.1016/0167-6296(91)90005-8Search in Google Scholar

Hall, R. und C. Jones (2007): The Value of Life and the Rise in Health Spending. Quarterly Journal of Economics 122, S. 39–72.10.1162/qjec.122.1.39Search in Google Scholar

Herr, A. und M. Suppliet (2012): Pharmaceutical prices under regulation: Tiered co-payments and reference pricing in Germany. DICE Discussion Paper 48.Search in Google Scholar

Hitiris, T. und J. Posnett (1992): The determinants and effects of health expenditure in developed countries. Journal of Health Economics, 11(2), S. 173–181.10.1016/0167-6296(92)90033-WSearch in Google Scholar

Jaumotte, F. und H. Morsy (2012): Determinants of inflation in the Euro Area: the role of labor and product market institutions. IMF Working Paper 12/37.10.5089/9781463933807.001Search in Google Scholar

Krugman, P. (1987): Pricing to Market When the Exchange Rate Changes. In: Arndt, S.W. und J.D. Richardson (Hrsg.): Real-financial linkages among open economies. MIT Press, Cambridge S. 49–70.Search in Google Scholar

Kyle, M. (2007): Pharmaceutical price controls and entry strategies. The Review of Economics and Statistics, 89(1), S. 88–99.10.1162/rest.89.1.88Search in Google Scholar

Kyle, M. (2011): Strategic responses to parallel trade. The BE Journal of Economic Analysis & Policy, 11(2), S. 1–32.10.2202/1935-1682.2629Search in Google Scholar

Malueg, D. und M. Schwartz (1994): Parallel imports, demand dispersion, and international price discrimination. Journal of International Economics, 37(3–4), S. 167–195.10.1016/0022-1996(94)90044-2Search in Google Scholar

Moscone, F. und E. Tosetti (2010): Health expenditure and income in the United States. Health Economics, 19(12), S. 1385–1403.10.1002/hec.1552Search in Google Scholar

Neubauer, G., Morasch, K. und A. Gmeiner (2013): Möglichkeiten und Vorteile einer Preisdifferenzierung bei innovativen Arzneimitteln. Studie für den Verband Forschender Arzneimittelhersteller e.V., Berlin.Search in Google Scholar

OECD (2003): A Disease-based Comparison of Health Systems: What is Best and at What Costs? OECD, Paris.Search in Google Scholar

Parkin, D., McGuire, A. und B. Yule (1987): Aggregate health care expenditures and national income: is health care a luxury good? Journal of Health Economics, 6(2), S. 109–127.10.1016/0167-6296(87)90002-6Search in Google Scholar

Przybyla, M. und M. Roma (2005): Does Product Market Competition Reduce Inflation? Evidence from EU Countries and Sectors. European Central Bank, Working Paper Series 453.10.2139/ssrn.676404Search in Google Scholar

Richardson, M. (2002): An elementary proposition concerning parallel imports. Journal of International Economics, 56(1), S. 233–245.10.1016/S0022-1996(01)00110-6Search in Google Scholar

Rogoff, K. (1996): The purchasing power parity puzzle. Journal of Economic Literature, 34(2), S. 647–668.Search in Google Scholar

Scherer, F. und J. Watal (2002): Post‐TRIPS Options for Access to Patented Medicines in Developing Nations. Journal of International Economic Law, 5(4), S. 913–939.10.1093/jiel/5.4.913Search in Google Scholar

Schreyögg, J., Tiemann, O., Stargardt, T. und R. Busse (2008): Cross-country comparisons of costs: the use of episode-specific transitive purchasing power parities with standardised cost categories. Health Economics, 17(S1), S. 95–103.10.1002/hec.1327Search in Google Scholar

Taylor, A.M. und M.P. Taylor (2004): The purchasing power parity debate. Journal of Economic Perspectives, 18(4), S. 135–58.10.1257/0895330042632744Search in Google Scholar